ANI Pharmaceuticals Inc.

NASDAQ: ANIP · Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:10 PM EDT

ANI Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
144.86M 221.12M 48.23M 100.3M
Short-Term Investments
6.31M n/a n/a n/a
Long-Term Investments
4.9M 6.2M 8.76M 5M
Other Long-Term Assets
7.32M 5.87M 2.6M 2.21M
Receivables
221.73M 162.08M 165.44M 128.53M
Inventory
136.78M 111.2M 105.36M 81.69M
Other Current Assets
18.01M 25.42M 16.85M 3.67M
Total Current Assets
527.68M 519.82M 344.26M 321.77M
Property-Plant & Equipment
56.86M 44.59M 43.25M 52.67M
Goodwill & Intangibles
601.82M 237.23M 279.86M 322.01M
Total Long-Term Assets
756.01M 384.61M 415.83M 449.82M
Total Assets
1.28B 904.42M 760.09M 771.6M
Account Payables
45.66M 36.68M 29.3M 22.97M
Deferred Revenue
n/a n/a n/a 87K
Short-Term Debt
9.17M 850K 850K 850K
Other Current Liabilities
77.03M 65.73M 33.4M 44.27M
Total Current Liabilities
193.68M 145.48M 99.44M 87.54M
Long-Term Debt
614.92M 284.82M 285.67M 286.52M
Other Long-Term Liabilities
42.02M 16.53M 35.06M 38.8M
Total Long-Term Liabilities
661.49M 301.35M 322.11M 325.32M
Total Liabilities
855.17M 446.82M 421.55M 412.86M
Total Debt
624.09M 285.67M 286.52M 287.37M
Common Stock
2K 2K 1K 1K
Retained Earnings
-100.28M -80.13M -97.29M -47.77M
Comprehensive Income
5.34M 8.86M 12.17M -3.06M
Shareholders Equity
428.53M 457.6M 338.54M 358.74M
Total Investments
6.31M 6.2M 8.76M 5M